Artivion AORT
NYSE AORT
$28.39 +0.41 (+1.47%)
As of: Aug 21, 2026 · 12:12 PM EDT

Artivion (AORT) Total Non-Current Liabilities (2010 - 2026)

Artivion's (AORT) quarterly Total Non-Current Liabilities came in at $423.5 million in Q1 2026, down 5.22% YoY from $446.9 million in Q1 2025, and down 0.92% on a QoQ basis from $427.5 million in Q4 2025.

Artivion (AORT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Artivion (AORT) has 17 years of Total Non-Current Liabilities data on file, last reported at $423.5 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 5.22% year-over-year to $423.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $423.5 million (down 5.22% YoY) and the FY2025 annual result came in at $427.5 million, down 15.33% from the prior year.
  • Total Non-Current Liabilities fell to $423.5 million in Q1 2026, from $427.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $504.8 million in Q4 2024 to a low of $409.5 million in Q2 2025.
  • A 5-year average of $449.4 million and a median of $442.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities advanced 13.01% — and 2025, when it declined 16.38%.
  • Tracing AORT's Total Non-Current Liabilities over 5 years: stood at $438.1 million in 2022, then rose by 1.98% to $446.7 million in 2023, then increased by 13.01% to $504.8 million in 2024, then fell by 15.33% to $427.5 million in 2025, then dropped by 0.92% to $423.5 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $423.5 million (Q1 2026), $427.5 million (Q4 2025), and $409.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 202.74 Bn 197.14 Bn 7.27 Bn -
2 Stryker 127.22 Bn 123.75 Bn 4.50 Bn 21.28 Bn
3 Medtronic 119.44 Bn 110.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.78 Bn 74.24 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.81 Bn 47.56 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.98 Bn 33.03 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.89 Bn 31.79 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.32 Bn 23.00 Bn 4.55 Bn 9.07 Bn
9 Steris 23.24 Bn 22.76 Bn 684.20 Mn 3.44 Bn
10 Artivion 1.38 Bn 1.30 Bn 80.52 Mn 554.83 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 554.83 Mn
Mar 31, 2026 423.53 Mn
Dec 31, 2025 427.46 Mn
Sep 30, 2025 409.69 Mn
Jun 30, 2025 409.53 Mn
Mar 31, 2025 446.86 Mn
Dec 31, 2024 504.84 Mn
Sep 30, 2024 489.93 Mn
Jun 30, 2024 446.28 Mn
Mar 31, 2024 442.62 Mn
Dec 31, 2023 446.73 Mn
Sep 30, 2023 440.51 Mn
Jun 30, 2023 487.88 Mn
Mar 31, 2023 431.96 Mn
Dec 31, 2022 438.07 Mn
Sep 30, 2022 480.97 Mn
Jun 30, 2022 476.66 Mn
Mar 31, 2022 436.76 Mn
Dec 31, 2021 485.84 Mn
Sep 30, 2021 494.87 Mn